The nation of Zimbabwe has rejected a substantial US health deal worth 367 million US dollars (£272m) spanning five years due to Washington's insistence on confidential information.
This rejection came to light after a government memo dated December was disclosed, which showed Head of State Emmerson Mnangagwa believed the arrangement was "unbalanced".
An official representative has since explained that the US was requesting health data for research and profit while refused to share the benefits from any future treatments.
"We must now begin the difficult and regrettable task of winding down our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the United States had furnished over $1.9bn in health funding to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has appealed for continued negotiations to secure a agreement acceptable to both sides so the country's critical HIV treatment initiative can be sustained.
Broader Background
This development follows a similar case in neighbouring Kenya, where a high court suspended a related deal with the US after legal challenges were filed about the safety of Kenyans' health data.
After resuming the presidency recently, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.
USAID had managed aid for the US government, but Trump stated its spending was "wasteful" and his administration was pursuing government-to-government agreements to boost transparency and responsibility.
As per reports, Sixteen African countries have to date agreed to similar health pacts, constituting more than $18.3bn in committed funds.
Specifics of the Rejected Deal
The funds for Zimbabwe was intended to funded "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this collaboration might have yielded significant advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on HIV treatment via American-funded initiatives," Tremont added.
However, government spokesperson Nick Mangwana said the arrangement was "unequal".
"Zimbabwe was being asked to provide its biological resources and data for a long time, with no equivalent promise of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that could be developed from that provided information," his statement read.
"Put simply, our nation would supply the raw materials for scientific discovery without any assurance that the resulting innovations would be available to our people if a future disease outbreak arise."
National Interest and Global Health
He also noted that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one deals were upending frameworks already established via the international health agency.
Mangwana cited its Pathogen Access and Benefit Sharing system designed to deal with potential pandemics.
"This system is intended to guarantee that when a nation provides its data, the benefits – including medicines and cures – are distributed fairly, not monopolised solely by those with the funds to create them."
The government's concerns regarding the US deal "must not be interpreted as hostility towards the US," he added.
"We welcome continued discussions with our American counterparts on how subsequent collaboration could be structured in a manner that respects the independence and dignity of each country."
Medical Community Reaction
A leading public health body said it understood the official position, but recommended that negotiations must proceed given that a large portion of the country's Aids initiatives depended on foreign aid.
"If technical issues arise, including those relating to data governance or agreement terms, these can often be addressed via detailed discussion and mutually agreed protections," it added.
The situation emphasises the ongoing challenges between accepting vital international aid and protecting a country's data in an increasingly interconnected world.